凱普生物(300639.SZ):子公司斥100萬元設立潮州康健 開展氯喹抑菌消毒產品研製
格隆匯2月14日丨凱普生物(300639.SZ)公佈,公司全資子公司廣州康健醫學科技有限公司(“廣州康健”)近日100%出資完成了潮州康健醫學科技有限公司(“潮州康健”)的工商設立登記,並取得由潮州市潮安區市場監督管理局核發的《營業執照》。
潮州康健醫學科技有限公司經營範圍:醫學研究和試驗發展;工程和技術研究和試驗發展;新材料技術開發、轉讓、推廣、諮詢服務;生產、銷售:衞生材料、衞生用品、醫療用品、消毒劑、消毒用品、醫療器械、化粧品、肥皂及合成洗滌劑、塑料製品;銷售:化工產品(不含危險化學品)、包裝材料、清潔用品。(依法須經批准的項目,經相關部門批准後方可開展經營活動。)(依法須經批准的項目,經相關部門批准後方可開展經營活動)。註冊資本:100.00萬人民幣。
公司基於磷酸氯喹在抗病毒方面的研究,已取得國家發明專利授權(專利名稱:一種氯喹凝膠及其製備方法和應用,專利號:ZL201811474701.3),並開發出藥品“磷酸氯喹凝膠”,目前正在開展臨牀試驗。
此次廣州康健在潮州投資設立潮州康健,計劃在潮州和廣州兩地共同將氯喹應用於消毒產品的研發和生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.